Prevalence, Pattern and Clinical Variations of Dermatophytosis in Patients with HIV Infection at the University of Port Harcourt Teaching Hospital, Port Harcourt

Main Article Content

Dasetima D. Altraide
Mary N. Amaewhule
Bolaji Otike-Odibi


Background: Immunosuppression due to various etiologies has been associated with the occurrence of dermatophytosis. Several studies in the past have demonstrated that Human Immunodeficiency Virus (HIV) infection is a risk factor for the acquisition and severity of dermatophytosis. This study examined the prevalence and clinical variations of dermatophytosis amongst HIV positive patients seen in Port-Harcourt, Southern Nigeria.

Methods: Between July 2019 and 2020 173 seropositive cases and 173 seronegative controls were recruited for this study. They were interviewed with a structured questionnaire and thereafter screened for the presence of dermatophytosis and sent for mycology studies.

Results: There was a higher prevalence of dermatophytosis in the HIV seropositive group when compared to the control group. Most of the lesions seen were not markedly different from that seen in immunocompetent persons. 41.65% of the cases were found among those with CD4 cell counts below 200. Tinea corporis was the commonest lesion seen (50%).  Trichophyton species was the commonest dermatophyte isolated, followed by Microsporum spp.

Conclusion: Prevalence of dermatophytosis is significantly higher in HIV infected patients and commonly occurs in advanced stages of the disease. Tinea corporis is the most common lesion in this group of patients and Trichophyton spp. a common causative agent.

Dermatophytosis, HIV, immunosuppression

Article Details

How to Cite
Altraide, D. D., Amaewhule, M. N., & Otike-Odibi, B. (2021). Prevalence, Pattern and Clinical Variations of Dermatophytosis in Patients with HIV Infection at the University of Port Harcourt Teaching Hospital, Port Harcourt. Asian Journal of Research in Infectious Diseases, 6(4), 33-43.
Original Research Article


Odunowo DB. pattern of dermatophytosis among out-patients seen in lagos university teaching hospital skin clinic; 1988.

Atraide DD, Akpa MR, George IO. The pattern of skin disorders in a Nigerian tertiary hospital. The Journal of Public Health and Epidemiology. 2011;3(4):177-181.

Braathen LR, Kaanan T. Human epidermal langerhan’s cells induce cellular immune responses to trichopyton in dermatophytosis. Br. J. Dermatol. 1983; 109:295-9.

Groh V, Mann DL, et al. Langerhan’s cells in HIV I infection. J. Am Cad. Dermatol. 1996;134(6):1124.

Stingl G, Rappersberger K, Tschachler E, Gartner S, Groh V, Mann DL, et al. Langerhan cell in HIV I infection. J. Am. Acad. Dermatol. 1990;22:1210-1217.

Barre-sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T- lymphotrophic retrovirus froma patient at risk for AIDS. Science. 1983;220:868–871.

Broder S, Gallo RC. A pathogenic retrovirus (HTLV III). Linked to AIDS. New England Journal of Medicine. 1984;311: 1292–1297.

Fauci AS, Clifford Lane H HIV disease AIDS and related disorders. In Braunward E, Hanser SL, Fauci AS, Long DL, Kasper DL, Jameson JL, Editors, Harrison’s Principle of internal medicaine 15th Edition. New york Mc-Graw Hill. 1852-1912;2.

Goodman DS, Teplitz ED, Wishner A, Klein RS, Burk PG, Hershenbaum E. Prevalence of cutaneous dieases in patients with AIDS or AIDS related complex. J. Am. Acad. Dermatology. 1987; 17:210–220.

Nnoruka EN. Chukwuka JC, Anisiuba B. Correlation of muscocutaneous manifestation of HIV/AIDS infection with CD4 counts and disease progression. Int. J. Dermatol. 2007;46(Suppl.2):14-8.

Shobhana A, Guhasubhasishkarnal, Neogi, DK. Indian Jourtnal of Dermatology Venerology and Leprology. 2004;70(2):82-86.

Ogunbiyib AO, Daramola OO, Alese OO. Prevalence of skin disease inn Ibadan Nigeria. Int. J. Dermatol. 2004;43(1):31-6.

Aly R, Berger T. Common superficial infections in patients with AIDS. Clinical infectious disease. 1996;22:5128–5132.

Ajao AO, Akintunde C. Studies on the prevalence of tinea capitis infection in Ile-ife, Nigeria. Mycopathologica. 1985;89(1): 43-8.

Ameh IG, Okolo RU. Dermatophytosis among school children in Nigeria: Domestic animals as predisposing factors in sokoto, Nigeria. Pakistan Journal of biological sciences. 2004;7(7);1109-1112.

Sanuth HA, Efuntoye MO Distribution and microbiological characteristics of dermatophyyte infection among primary school children in Ago-Iwoye, Oguun state, Nigeria. Reasearcher. 2010;2(12):80-85.

Ndako JA, Osemwegie OO, Spencer TH, Olopade BK, Yunusa G, Banda J. Prevalence of dermatophytosis and other associated fungi among school children. Global advanced research journey of medicine and medicinal science. 2012; 1(3):049-056.

Akinboro AO, Olasode AO, Onayemi O. The pattern, risk factors and clinic-aetiological correlates of tinea captitis among the children in a tropical community setting of osogbo, southwestern Nigeria. Afro-Egypt J. Infect. Enderm. Dis. 2011; 1(2):53-64.

Soyinka F. Epidemiological study of dermatophyte infections in Nigeria (clinical survey and laboratory investigations). Mycopathologia 1978;63(2):99–103.

Kaviarasan PK, Jaisankar TJ, Thappa DM, Sujatha S. Clinical variations in dermatophytosis in HIV infected patients. Indian Journal of Dermatophytosis in HIV infected patients. Indian Journal of Dermatology, Venerology and Leprology. 2002;68:213–216.

Ekong A, Uwa I. Grant – prevalence and types of opportunistic infections in HIV/AIDS Patients in Nigeria. 5th international congress on Drugs Therapy in HIV infection. Glasgow UK. 2000;22–26.

Coldrion BM, Bergshesser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch. Dermatol. 1989;125:357-61.

Pennys NS. Skin manifestation of AIDS. London Martin. Dumitz; 1995.

Ho KM, Wong KH, Lee SS, eds. HIV manual. 2001;231-245.

Raju PV, Rao GR, Ramari TV, Vandana S. Skin disease clinical indicator of immunostatus in human immunodeficiency virus (HIV) infection. Int J. Dermatol. 2005;44:646-9.

Kumarasamy N, Solomon S, Madhivanan P, Ravikumar B, Thyagarajan SP, Yesudian P. Dermatologic manifestations among human immunodeficiency virus patients in South India. Int J. Dermatol. 2000;39:192-195.

Singh A, Thappa DM, Hamide A. The spectrum of mucocutaneous manifestations during the evolutionary phases of HIV disease. An emerging Indian scenario. J. Dermatol. (Tokyo) 1999;26:294-304.

Rajesh R, Subramanian K, Padmavasthy BK, Vasanthi S. Prevalence and specie profile of dermatophytosis among HIV positive patients in a rural referral Centre. Indian J. Sex. Transm. Dis. 2006;27(2)70.

Satiya VSA, Singh VP, Shyam S, Gulati AK, Varma DV, Rai M. Relationship between skin diseases and cd4 cell count in a hospital based cohort of HIV infected adults in North India. Journal, Indian Academy of Clinical Medicine. 2008;9(1): 20-25.

Conant MA. The AIDS epidemic. J Am Acad Dermatol. 1994;31(3pt2):s47-50.

Umoru DD, Esene H. Clinical characteristics of dermatophytosis among children in a Nigeria population; the role of HIV/AIDS Benin journal of postgraduate medicine. 2010;12(1):32-36.

Adriano S, Valeri B, Giuliano B, Gingio B, Anna M, Severino S. Prevalence of dermatophytosis and yeasts in HIV patients. Mycopathologia. 1991;14(2):103-107.
DOI: 1007/BF0043629

Amar S, Ratnakar K, Chetan O, Dattatray S, Minal T, Sujata T, et al. A clinical and mycological study of onychomycosis in HIV infection Indian J. Dermatol Venereal Leprol. 2007;397-401.

Bakos L, Bonamigo RR, Pisani AC, Mariante JC, Mallman R. Scutular favus-like tinea cruris et pedis in a patient with AIDS. J Am Acad Dermatol. 1996; 34:1086-7.

Primary cutaneous aspergillosis in Human Immunodeficiency virus – infected patients. Clinical infectious Diseases. 1998;27(3): 641-643.

Channe N, Tankhiwale SS. Study of dermatophytosis in a Tertiary Care Centre in Central India. Journal of Evolution of Medical and Dental Sciences. 2021; 10(8):484-8.